Significance, prognostic value and management of heart rate in hypertension

Archives of Cardiovascular Diseases

Volumn 107, Issue 1, 2014, Pages 48-57

  Courand, Pierre Yves ^a,b,c   Lantelme, Pierre ^a,b,c  

^a CROIX ROUSSE HOSPITAL   (France)

^b University Lyon 1   (France)

^c Service de cardiologie Hôpital Nord Ouest   (France)

Author keywords

Heart rate; Hypertension; Mortality; Prognostic value

Indexed keywords

FRÉQUENCE CARDIAQUE; HEART RATE; HYPERTENSION; MORTALITÉ; MORTALITY; PROGNOSTIC VALUE; VALEUR PRONOSTIQUE;

ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART RATE; HUMANS; HYPERTENSION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84895077203     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2013.11.003     Document Type: Review

References (80)

1. A. Benetos, A. Rudnichi, and F. Thomas et al. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure Hypertension 33 1999 44 52
2. A.R. Dyer, V. Persky, and J. Stamler et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies Am J Epidemiol 112 1980 736 749
3. X. Jouven, J.P. Empana, and P.J. Schwartz et al. Heart-rate profile during exercise as a predictor of sudden death N Engl J Med 352 2005 1951 1958
4. W.B. Kannel, C. Kannel, and R.S. Paffenbarger Jr. et al. Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1987 1489 1494
5. E. Kristal-Boneh, H. Silber, and G. Harari et al. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study) Eur Heart J 21 2000 116 124
6. E. Disegni, U. Goldbourt, and H. Reicher-Reiss et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial J Clin Epidemiol 48 1995 1197 1205
7. K. Fox, I. Ford, and P.G. Steg et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
8. R. Kolloch, U.F. Legler, and A. Champion et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST) Eur Heart J 29 2008 1327 1334
9. M. Bohm, K. Swedberg, and M. Komajda et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
10. P. Lechat, J.S. Hulot, and S. Escolano et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial Circulation 103 2001 1428 1433
11. S.J. Pocock, D. Wang, and M.A. Pfeffer et al. Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75
12. H.S. Bassiouny, C.K. Zarins, and M.H. Kadowaki et al. Hemodynamic stress and experimental aortoiliac atherosclerosis J Vasc Surg 19 1994 426 434
13. P.A. Beere, S. Glagov, and C.K. Zarins Retarding effect of lowered heart rate on coronary atherosclerosis Science 226 1984 180 182
14. J.R. Kaplan, S.B. Manuck, and M.R. Adams et al. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet Circulation 76 1987 1364 1372
15. E.G. Nabel, A.P. Selwyn, and P. Ganz Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate Circulation 81 1990 850 859
16. U.E. Heidland, and B.E. Strauer Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption Circulation 104 2001 1477 1482
17. S. Bangalore, F.H. Messerli, and F.S. Ou et al. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135,164 patients in the CRUSADE quality improvement initiative Eur Heart J 31 2010 552 560
18. A. Diaz, M.G. Bourassa, and M.C. Guertin et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur Heart J 26 2005 967 974
19. K. Fox, I. Ford, and P.G. Steg et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
20. J. Kjekshus Heart rate reduction-a mechanism of benefit? Eur Heart J 8 Suppl. L 1987 115 122
21. S. Julius, O.S. Randall, and M.D. Esler et al. Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension Circ Res 36 1975 199 207
22. H. Ashrafian, M.P. Frenneaux, and L.H. Opie Metabolic mechanisms in heart failure Circulation 116 2007 434 448
23. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
24. H.A. Himburg, S.E. Dowd, and M.H. Friedman Frequency-dependent response of the vascular endothelium to pulsatile shear stress Am J Physiol Heart Circ Physiol 293 2007 H645 H653
25. A.R. Brooks, P.I. Lelkes, and G.M. Rubanyi Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow Physiol Genomics 9 2002 27 41
26. S. Lehoux Redox signalling in vascular responses to shear and stretch Cardiovasc Res 71 2006 269 279
27. W. Durante, L. Liao, and S.V. Reyna et al. Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle FASEB J 14 2000 1775 1783
28. J.P. Stegemann, H. Hong, and R.M. Nerem Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype J Appl Physiol (1985) 98 2005 2321 2327
29. E. Wilson, Q. Mai, and K. Sudhir et al. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF J Cell Biol 123 1993 741 747
30. C.A. Simmons, J. Nikolovski, and A.J. Thornton et al. Mechanical stimulation and mitogen-activated protein kinase signaling independently regulate osteogenic differentiation and mineralization by calcifying vascular cells J Biomech 37 2004 1531 1541
31. S. Lehoux, B. Esposito, and R. Merval et al. Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species Arterioscler Thromb Vasc Biol 20 2000 2366 2372
32. T.S. Church, C.P. Earnest, and J.S. Skinner et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial JAMA 297 2007 2081 2091
33. J.M. Curtis, E.S. Horton, and J. Bahnson et al. Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study Diabetes Care 33 2010 901 907
34. P. Palatini, L. Mos, and M. Santonastaso et al. Resting heart rate as a predictor of body weight gain in the early stage of hypertension Obesity (Silver Spring) 19 2011 618 623
35. Y. Shigetoh, H. Adachi, and S. Yamagishi et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population Am J Hypertens 22 2009 151 155
36. K.A. Jamerson, S. Julius, and T. Gudbrandsson et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm Hypertension 21 1993 618 623
37. R.J. Zeman, R. Ludemann, and T.G. Easton et al. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist Am J Physiol 254 1988 E726 E732
38. K. Masuo, H. Kawaguchi, and H. Mikami et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation Hypertension 42 2003 474 480
39. S. Julius, M. Valentini, and P. Palatini Overweight and hypertension: a 2-way street Hypertension 35 2000 807 813
40. B. Williams, P.S. Lacy, and Cafe et al. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate J Am Coll Cardiol 54 2009 705 713
41. B. Williams, P.S. Lacy, and S.M. Thom et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
42. P. Laurent, P. Albaladejo, and J. Blacher et al. Heart rate and pulse pressure amplification in hypertensive subjects Am J Hypertens 16 2003 363 370
43. M.E. Safar, A.D. Protogerou, and J. Blacher Statins, central blood pressure, and blood pressure amplification Circulation 119 2009 9 12
44. P. Lantelme, and P.Y. Courand [Clinical value of central blood pressure] Presse Med 40 2011 700 706
45. T. Inoue, K. Iseki, and C. Iseki et al. Higher heart rate predicts the risk of developing hypertension in a normotensive screened cohort Circ J 71 2007 1755 1760
46. P. Palatini, F. Dorigatti, and V. Zaetta et al. Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study J Hypertens 24 2006 1873 1880
47. P. Lantelme, C. Mestre, and M. Lievre et al. Heart rate: an important confounder of pulse wave velocity assessment Hypertension 39 2002 1083 1087
48. A. Benetos, C. Adamopoulos, and J.M. Bureau et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period Circulation 105 2002 1202 1207
49. F. Saladin, E. Benetti, and L. Mos et al. Evolution of parameters of arterial distensibility in a cohort of young-to-middle-age hypertensive subjects J Hypertens 28 2010 e176
50. H. Tomiyama, H. Hashimoto, and H. Tanaka et al. Synergistic relationship between changes in the pulse wave velocity and changes in the heart rate in middle-aged Japanese adults: a prospective study J Hypertens 28 2010 687 694
51. M. Bohm, J.C. Reil, and N. Danchin et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH J Hypertens 26 2008 18 25
52. P.Y. Courand, H. Milon, and M.P. Gustin et al. Effect modification of aortic atheroma on the prognostic value of heart rate in hypertension J Hypertens 31 2013 484 491 [discussion 91]
53. M.W. Gillman, W.B. Kannel, and A. Belanger et al. Influence of heart rate on mortality among persons with hypertension: the Framingham Study Am Heart J 125 1993 1148 1154
54. P. Palatini, L. Thijs, and J.A. Staessen et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension Arch Intern Med 162 2002 2313 2321
55. L. Paul, C.E. Hastie, and W.S. Li et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients Hypertension 55 2010 567 574
56. F. Thomas, A. Rudnichi, and A.M. Bacri et al. Cardiovascular mortality in hypertensive men according to presence of associated risk factors Hypertension 37 2001 1256 1261
57. P.M. Okin, S.E. Kjeldsen, and S. Julius et al. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy Eur Heart J 31 2010 2271 2279
58. S. Julius, P. Palatini, and S.E. Kjeldsen et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension Am J Cardiol 109 2012 685 692
59. A. Hozawa, T. Ohkubo, and M. Kikuya et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study Am J Hypertens 17 2004 1005 1010
60. P. Verdecchia, G. Schillaci, and C. Borgioni et al. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension J Hypertens 16 1998 1335 1343
61. I.Z. Ben-Dov, J.D. Kark, and D. Ben-Ishay et al. Blunted heart rate dip during sleep and all-cause mortality Arch Intern Med 167 2007 2116 2121
62. T.W. Hansen, L. Thijs, and J. Boggia et al. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations Hypertension 52 2008 229 235
63. P. Palatini, G. Reboldi, and L.J. Beilin et al. Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study Int J Cardiol 168 2013 1490 1495
64. P. Palatini, A. Benetos, and G. Grassi et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting J Hypertens 24 2006 603 610
65. R. Sega, R. Facchetti, and M. Bombelli et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study Circulation 111 2005 1777 1783
66. J. Blacher, J.M. Halimi, and O. Hanon et al. [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension] Presse Med 42 2013 819 825
67. V.K. Somers, M.E. Dyken, and M.P. Clary et al. Sympathetic neural mechanisms in obstructive sleep apnea J Clin Invest 96 1995 1897 1904
68. Medical Research Council Working Party MRC trial of treatment of mild hypertension: principal results Br Med J (Clin Res Ed) 291 1985 97 104
69. B. Dahlof, P.S. Sever, and N.R. Poulter et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 2005 895 906
70. L. Hansson, L.H. Lindholm, and L. Niskanen et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial Lancet 353 1999 611 616
71. J.R. Kizer, B. Dahlof, and S.E. Kjeldsen et al. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study Hypertension 45 2005 46 52
72. N.R. Poulter, J.E. Dobson, and P.S. Sever et al. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) J Am Coll Cardiol 54 2009 1154 1161
73. L. Wilhelmsen, G. Berglund, and D. Elmfeldt et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial J Hypertens 5 1987 561 572
74. S. Bangalore, S. Sawhney, and F.H. Messerli Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension J Am Coll Cardiol 52 2008 1482 1489
75. A. Lehtonen Effect of beta blockers on blood lipid profile Am Heart J 109 1985 1192 1196
76. Z. Dhakam, and C.M. Yasmin McEniery et al. A comparison of atenolol and nebivolol in isolated systolic hypertension J Hypertens 26 2008 351 356
77. L. Hansson, T. Hedner, and P. Lund-Johansen et al. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study Lancet 356 2000 359 365
78. C.J. Pepine, E.M. Handberg, and R.M. Cooper-DeHoff et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
79. P. Lantelme, P.Y. Courand, and A. Pathak Renal denervation: a plea for wisdom Arch Cardiovasc Dis 106 2013 121 123
80. C. Ukena, F. Mahfoud, and A. Spies et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension Int J Cardiol 167 2013 2846 2851